Who owns ImmunityBio, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IBRX from SEC Form 13F filings across 405 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 405 institutions disclosed 201.9M shares of ImmunityBio, Inc. worth $1.77B — about 19.2% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
405
13F holders
$1.77B
value, 2026 filers
19.2%
of shares outstanding (201.9M sh)
69
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of IBRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 34.1M | $298.4M | 0.0% | 3.2% | +29.4% |
| 2 | STATE STREET CORP | 21.4M | $187.3M | 0.0% | 2% | +20.8% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 17.9M | $156.4M | 0.0% | 1.7% | +9.4% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 15.7M | $137.4M | 0.0% | 1.5% | +3.7% |
| 5 | D. E. Shaw & Co., Inc. | 11.6M | $101.1M | 0.0% | 1.1% | -8.1% |
| 6 | TWO SIGMA INVESTMENTS, LP | 11.1M | $97.2M | 0.1% | 1.1% | +153.0% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 9.8M | $86.2M | 0.0% | 0.9% | +22.6% |
| 8 | MILLENNIUM MANAGEMENT LLC | 5.6M | $48.9M | 0.0% | 0.5% | +292.9% |
| 9 | NORTHERN TRUST CORP | 3.6M | $31.2M | 0.0% | 0.3% | +42.3% |
| 10 | MORGAN STANLEY | 3.4M | $30.1M | 0.0% | 0.3% | -14.6% |
| 11 | GOLDMAN SACHS GROUP INC | 3.2M | $28.3M | 0.0% | 0.3% | -0.1% |
| 12 | UBS Group AG | 3.2M | $28.0M | 0.0% | 0.3% | +8.5% |
| 13 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.9M | $25.3M | 0.0% | 0.3% | +16.6% |
| 14 | Woodline Partners LP | 2.5M | $21.9M | 0.1% | 0.2% | -27.5% |
| 15 | SEB Asset Management AB | 2.4M | $21.4M | 0.1% | 0.2% | 0.0% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 2.4M | $21.1M | 0.0% | 0.2% | +13.6% |
| 17 | BANK OF AMERICA CORP /DE/ | 2.2M | $19.1M | 0.0% | 0.2% | -10.8% |
| 18 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1.7M | $15.1M | 0.1% | 0.2% | -41.2% |
| 19 | FEDERATED HERMES, INC. | 1.7M | $15.0M | 0.0% | 0.2% | +23.6% |
| 20 | ROYAL BANK OF CANADA | 1.5M | $13.5M | 0.0% | 0.1% | +3.8% |
| 21 | JPMORGAN CHASE & CO | 1.5M | $12.9M | 0.0% | 0.1% | -2.6% |
| 22 | Bank of New York Mellon Corp | 1.3M | $11.5M | 0.0% | 0.1% | +58.1% |
| 23 | FIRST TRUST ADVISORS LPNEW | 1.2M | $10.6M | 0.0% | 0.1% | new |
| 24 | Cetera Investment Advisers | 1.1M | $10.0M | 0.0% | 0.1% | +20.5% |
| 25 | Sound Capital Solutions LLCNEW | 1.1M | $9.8M | 2.3% | 0.1% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.